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Abstract
Zinc finger MYND-type-containing 10 (ZMYND10), a cytoplasmic protein expressed in cili-
ated cells, causes primary ciliary dyskinesia (PCD) when mutated; however, its function is
poorly understood. Therefore, in this study, we examined the roles of ZMYND10 using
Zmynd10–/–mice exhibiting typical PCD phenotypes, including hydrocephalus and laterality
defects. In these mutants, morphology, the number of motile cilia, and the 9+2 axoneme
structure were normal; however, inner and outer dynein arms (IDA and ODA, respectively)
were absent. ZMYND10 interacted with ODA components and proteins, including LRRC6,
DYX1C1, and C21ORF59, implicated in the cytoplasmic pre-assembly of DAs, whose levels
were significantly reduced in Zmynd10–/–mice. LRRC6 and DNAI1 were more stable when
co-expressed with ZYMND10 than when expressed alone. DNAI2, which did not interact
with ZMYND10, was not stabilized by co-expression with ZMYND10 alone, but was stabi-
lized by co-expression with DNAI1 and ZMYND10, suggesting that ZMYND10 stabilized
DNAI1, which subsequently stabilized DNAI2. Together, these results demonstrated that
ZMYND10 regulated the early stage of DA cytoplasmic pre-assembly by stabilizing DNAI1.
Author summary
Dynein arm defects are linked to primary ciliary dyskinesia (PCD). ZMYND10 increased
the stability of its interacting proteins and specifically regulated intermediate chain pro-
tein assembly, revealing tightly regulated mechanisms underlying dynein arm assembly
and PCD-related pathogenesis. Increasing protein stability could be useful for developing
PCD therapeutics.
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Introduction
Primary ciliary dyskinesia (PCD) is an autosomal-recessive disorder caused by defective motile
cilia or flagella that is characterized by respiratory distress, impaired mucociliary clearance,
chronic cough, sinusitis, bronchiectasis, male infertility, laterality defects, and cardiac anoma-
lies in term neonates [1, 2]. To date, mutations in about 30 genes have been linked to PCD in
approximately 50–70% of cases [3].
In motile cilia or flagella, the outer dynein arm (ODA) and inner dynein arm (IDA) are
attached to the peripheral microtubules of the 9+2 axoneme with a fixed periodicity and gener-
ate ATP-dependent motion. Dynein arms are large, multisubunit protein complexes com-
prised of light, intermediate, and heavy chains [4]. The latter have ATPase activity, which
provides power for the sliding between microtubules in the beating cilia. The capacity of the
dynein arm to function as molecular motors depends on the integrity of its components. ODA
consists of two to three heavy chains, two or more intermediate chains, and a cluster of four to
eight light chains, whereas IDA has a more diverse composition [4, 5]. As such, several genes
linked to PCD encode dynein arm components, including dynein axonemal light chain 1
(DNAL1), dynein axonemal intermediate chain 1 (DNAI1), DNAI2, dynein axonemal heavy
chain 5 (DNAH5), and DNAH11 [6–10]. Mutations in DNAH6, a heavy chain of IDA, were
detected in individuals with heterotaxy and ciliary dysfunction [11].
Dynein arms are pre-assembled in the cytoplasm and transported into motile cilia, where
they are docked onto peripheral microtubules; however, the underlying mechanisms are
poorly understood [12]. Dynein axonemal assembly factors (DNAAFs) are involved in the
pre-assembly of dynein arms, and their mutation is linked to PCD [13–16]. There are five
known DNAAFs—leucine-rich repeat-containing 50 (LRRC50, DNAAF1) [13], kintoun
(KTU, DNAAF2) [14], DNAAF3 [15], dyslexia susceptibility 1 candidate 1 (DYX1C1,
DNAAF4) [16], and HEAT repeat-containing protein 2 (HEATR2, DNAAF5) [17]. KTU and
DYX1C1 interact with chaperone proteins, including heat shock protein 70 (HSP70), HSP90,
and T-complex chaperonin complex [14, 16]. DNAAFs work with a chaperone complex to
facilitate the proper folding of heavy chains and their assembly with intermediate chains [15].
Defects in DNAAFs result in the loss of ODAs and IDAs from axonemes [13–16].
In addition to DNAAFs, mutations in several cytoplasmic proteins, including LRRC6 [18,
19], zinc finger MYND-type-containing 10 (ZMYND10) [20, 21], chromosome 21 open read-
ing frame 59 (C21ORF59) [22], PIH1 domain-containing 3 (PIH1D3) [23, 24], and armadillo
repeat-containing 4 (ARMC4) [25], have been identified as those causing PCD when defective.
Mutations in LRRC6, ZMYND10, C21ORF59, and PIH1D3 cause ODA and IDA defects [18–
24], whereas those in ARMC4 cause ODA defects [25]. Thus, these proteins likely function at
different stages of pre-assembly or have ODA- or IDA-specific roles. Overall, these proteins
are expected to be involved in the pre-assembly of dynein arms based on their cytoplasmic
localization and consequences upon loss of expression. However, the specific functions of
these proteins and their relationships with DNAAFs are not well understood.
ZMYND10 (also known as BLU) has a myeloid, nervy, and DEAF-1 (MYND)-type zinc fin-
ger domain at its C-terminus that engages in protein-protein interactions [26]. ZMYND10 is
highly enriched in ciliated cells compared with that in nonciliated cells [27] and is expressed in
motile ciliated tissues in mice [21]. ZMYND10 has been shown to interact with LRRC6 [20,
21], although its function in motile ciliated cells is not known. Therefore, in this study, we gen-
erated and characterized Zmynd10−/− mice and found that they recapitulate phenotypic aspects
of human PCD, including the absence of ODA and IDA without defects in ciliogenesis or 9+2
axonemal structure. We also found that the levels of DNAI1 and DNAI2 in ODA were reduced
in Zmynd10−/− mice. ZYMND10 binds to and stabilizes DNAI1, thereby facilitating the
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assembly of intermediate chains. Our data suggested that ZMYND10 may play a role in the
pre-assembly of dynein arms by regulating the expression of dynein arm components at the
protein, and not the mRNA level and promoting their assembly into a cytoplasmic protein
complex.
Results
Zmynd10−/− mice recapitulated human PCD phenotypes
To investigate the function of ZMYND10, we generated mice with targeted deletion of the
Zmynd10 gene locus (S1A and S1B Fig) using a lacZ-containing targeting cassette
(Zmynd10tm1[KOMP]Wtsi). β-Galactosidase activity staining of Zmynd10+/− lung tissues on post-
natal day (P)1 revealed Zmynd10 expression in the bronchus and bronchioles, but not in the
alveoli (S1C and S1D Fig). This expression pattern was consistent with that in the previous in
situ hybridization results in mouse lung tissues [21]. Zmynd10 expression was also observed in
the testes of Zmynd10+/− mice at P28 as well as in the spermatids and earlier-stage germ cells
(S1E and S1F Fig). Deletion of coding exons 2–11 yielded a Zmynd10-null allele (Zmynd10−/−),
and western blotting and immunofluorescence analyses of the testis lysates and tracheal tissue,
respectively, confirmed the absence of ZMYND10 (S2 Fig).
Zmynd10−/− mouse litters conformed to Mendelian ratios, and neonates showed no gross
abnormalities, indicating that loss of Zmynd10 did not cause embryonic lethality; however,
mutant mice exhibited growth retardation and were visibly smaller at P10, with all eventually
dying within 1 month of birth (S3A–S3C Fig), with a mean survival of 14 days. Zmynd10−/−
mice developed hydrocephaly and subsequent abnormal head morphology, with complete
penetrance (Fig 1A and 1B), and the cerebral ventricles were dilated with cortical tissue thin-
ning (Fig 1C–1F). In addition, 42% of the Zmynd10−/− mice showed laterality defects, includ-
ing reversal of the heart apex, stomach, liver, or spleen (S3E and S3F Fig). Alcian Blue staining
of the paranasal cavities revealed mucosal congestion in Zmynd10−/− mice but not in wild-type
littermates, suggesting defective mucociliary clearance (Fig 1G and 1H), which is a prominent
manifestation of PCD leading to recurrent airway infection. Inflammation in the lung tissue
was never observed in Zmynd10−/− mice that died before P20; however, some of the mice that
survived past P25 showed severe pulmonary inflammation in mutants, as evidenced by loss of
alveolar architecture, thickening of alveolar septae, collapse of the alveolar space, and infiltra-
tion of inflammatory cells and fibroblasts (Fig 1I–1J and S3D Fig). Fibrosis was not observed
in Masson trichrome staining (Fig 1K and 1L). Taken together, these data indicated that loss of
Zmynd10 induced defects consistent with PCD.
Loss of Zmynd10 caused axoneme ODA and IDA defects
Since the Zmynd10−/− phenotype suggested defects in motile cilia, we examined their ultra-
structure by transmission electron microscopy (TEM). The tracheal cilia and basal bodies were
abundant in the tracheal and lung epithelial cells in both Zmynd10+/+ and Zmynd10−/− mice
(Fig 2A–2D and S4 Fig); however, in the latter, some areas of the tracheal epithelium were sur-
rounded by cellular debris and mucus (S4 Fig). Analysis of the tracheal cilia cross-sections
revealed a typical 9+2 microtubular structure in both wild-type and Zmynd10−/− mice (Fig 2E
and 2F). In contrast, cilia in Zmynd10−/− mice lacked both ODA and IDA structures (Fig 2H),
which were present in the peripheral microtubules of Zmynd10+/+ mice (Fig 2G). This is in
agreement with the previous results of studies on humans subjects with ZMYND10mutations
who lacked ODA and IDA in the respiratory epithelium [20, 21]. The observed defects in the
ciliary structure resulted in a loss of ciliary motility and beating in the ventricles of the
Zmynd10−/− brain (S1 Movie and S2 Movie). However, ciliogenesis itself was normal, as
ZMYND10 in dynein arm pre-assembly
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demonstrated by the observation that the numbers of cilia and basal bodies were not different
between Zmynd10+/+ and Zmynd10−/− mice (Fig 2I and 2J).
The subcellular distribution of the ODA intermediate chain protein DNAI2 in mouse tra-
cheal epithelial cells (mTECs) cultured at the air-liquid interface (ALI) for 14 days was exam-
ined by immunofluorescence microscopy. In mTECs from Zmynd10+/+ mice, DNAI2 was
detected in both cilia and cytoplasm and was found to colocalize with the ciliary marker acety-
lated α-tubulin (Fig 2K and S5A Fig). In contrast, DNAI2 was only weakly expressed in the
cytoplasm of mTECs from Zmynd10−/− mice and did not colocalize with acetylated α-tubulin,
suggesting that DNAI2 was significantly decreased and failed to translocate to motile cilia in
the absence of Zmynd10 (Fig 2L and S5B Fig). Thus, the phenotypes observed in Zmynd10−/−
mice resulted from a ciliary motility defect associated with the loss of axonemal ODA and IDA.
Transcript levels of ODA and IDA components were unaltered in
Zmynd10−/− mice
The mRNA levels of DNAH5 and DNALI1—ODA heavy and IDA light-intermediate chain
proteins, respectively—were downregulated by ZMYND10 knockdown in cultured human
tracheal epithelial cells [20]. This was examined in Zmynd10+/+ and Zmynd10−/− mice by tran-
scriptional profiling/RNA sequencing using total RNA extracted from the testis, lung, and
brain tissues (S1 Table). The transcript levels of ODA and IDA components in mutants were
similar to those in wild-type mice (Fig 3), suggesting that ZMYND10 did not regulate the tran-
scription of dynein arm components. Gene ontology analysis showed that genes involved in
muscle function were significantly upregulated, whereas those involved in ion transport were
reduced in Zmynd10-/- mice compared with those in Zmynd10+/+ mice (S6 Fig).
ZMYND10 formed a cytoplasmic protein complex
We and others previously reported that ZMYND10 interacts with LRRC6 [20, 21]. Given that
both proteins are cytoplasmic, we examined whether they interacted with other cytoplasmic
proteins that are known to be defective in PCD by co-immunoprecipitation in human embry-
onic kidney (HEK) 293T cells. We also obtained potential interactors from a web-based pro-
tein-protein interaction database, PrePPI (https://honiglab.c2b2.columbia.edu/PrePPI/index_
old.html). ZMYND10 was found to interact with C21ORF59 and DYX1C1 (DNAAF4), IQ
motif and ubiquitin domain-containing protein (IQUB), Tctex1 domain-containing D1
(TCTEX1D1), and DNAI1, but not with DNAI2 (S7 Fig). TCTEX1D1 is a dynein light chain
of ODA [5], and one of the intermediate chain proteins of ODA, DNAI1, interacts with
ZMYND10. Interactions with LRRC6 and REPTIN, which are essential for cilia motility [28],
as well as interactions with C21ORF59, DNAI1, and IQUB were confirmed by glutathione S-
transferase (GST) pulldown assays using lysates from mTECs (Fig 4A). In addition, we found
that ZMYND10 interacted with heat shock cognate protein 70 (HSC70), a constitutively
expressed molecular chaperone (S8 Fig), suggesting that ZMYND10 played a role in the fold-
ing and assembly of dynein arms through cooperation with HSC70. These protein-protein
Fig 1. Zmynd10−/− mice exhibited phenotypes consistent with cilia motility defects. (A, B) Unlike Zmynd10+/+ mice (A),
Zmynd10−/− mice (B) exhibited characteristic head deformation resulting from severe hydrocephalus. (C, D) The coronal brains
sections showed enlarged ventricular cavity and reduced cortical thickness in Zmynd10−/− mice. (E, F) Hematoxylin and eosin
(H&E) staining of the coronal brain sections showed expanded ventricles in Zmynd10−/− mice. Scale bars, 1 mm. (G, H) Alcian Blue
staining of the paranasal cavities showed mucus congestion along the nasal epithelium in Zmynd10−/− mice. Scale bars, 1 mm. (I–L)
H&E staining and Masson’s trichrome staining of Zmynd10+/+ (I, K) and Zmynd10−/− (J, L) mouse lung sections at P29 showed
marked interstitial widening due to inflammatory infiltrates and edema. Original magnification, 40× (scale bar, 500 μm), 100×, and
200× (scale bar, 100 μm).
https://doi.org/10.1371/journal.pgen.1007316.g001
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interactions are illustrated in Fig 4B. REPTIN and C21ORF59 expression was also examined
in mTECs at ALI 14 by immunofluorescence microscopy. REPTIN and C21ORF59 signals
were reduced in Zmynd10−/− mTECs (Fig 4C–4E and S9 Fig). Interestingly, C21ORF59 was
recently shown to interact with LRRC6 and Dishevelled (Dvl) and is implicated in planar cell
polarity as well as the correct localization of ODAs to motile cilia [29]. Our results demon-
strated that ZMYND10 interacted with cytoplasmic proteins associated with PCD and that
some interaction partners were downregulated in the absence of Zmynd10.
Fig 2. Zmynd10−/− mice exhibited ODA and IDA defects. (A–D) TEM analysis of Zmynd10+/+ and Zmynd10−/− multiciliated cells from the
trachea of P14 mice. The number and morphology of cilia and basal bodies were similar between Zmynd10−/− (B, D) and Zmynd10+/+ (A, C) mice.
Scale bars, 500 μm. (E, F) TEM micrographs of the motile cilia axonemes showing normal 9+2 microtubule structures in both Zmynd10+/+ and
Zmynd10−/− mice. Scale bars, 500 μm. (G, H) ODAs and IDAs (white arrows) were observed in the peripheral microtubule doublets of motile cilia in
Zmynd10+/+ mice (G); however, ODAs and IDAs were absent in ciliary axonemes of Zmynd10−/− mice (H, black arrows). Scale bars, 500 μm. (I, J)
Cilia (I) and basal bodies (J) were counted in TEM images of tracheas of Zmynd10+/+ and Zmynd10−/− mice. (K, L) Immunofluorescence analysis of
acetylated α-tubulin (Ac-α-tub, green) and DNAI2 (red) expression in mTEC cultures at ALI day 14. DNAI2 was significantly decreased and did
not colocalize with acetylated α-tubulin in Zmynd10−/− mTECs, suggesting that motile cilia lacked ODAs (J). Scale bars, 10 μm.
https://doi.org/10.1371/journal.pgen.1007316.g002
Fig 3. ZMYND10 did not regulate mRNA expression of dynein arm components. (A–C) Graphs comparing reads per kilobase of transcript per million mapped
reads (RPKM) of ODA and IDA components. Total RNA was isolated from the P21 testis (A), P14 lung (B), and P14 brain (C) tissues from Zmynd10+/+ and
Zmynd10−/− mice. The expression of most dynein arm components did not differ between wild-type and mutant mice.
https://doi.org/10.1371/journal.pgen.1007316.g003
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ZMYND10 stabilized the cytoplasmic protein complex and regulated the
pre-assembly of the dynein arm in the cytoplasm
Our results in mTECs suggested that protein levels of dynein arm components (Fig 2K and
2L) and their interaction partners (Fig 4C–4E) were altered in Zmynd10−/− mice. To investi-
gate this in detail, immunoblotting was carried out using the testis lysates. The levels of pro-
teins that interacted with ZMYND10, such as C21ORF59, IQUB, and LRRC6, as well as
dynein arm subunits, including DNAI1, DNAI2, and DNAH7, a heavy chain of inner dynein
arm, were downregulated in mutant mice (Fig 5A and 5B). This was also confirmed by immu-
nofluorescence analysis of the mouse tracheal tissue. DNAH5, DNAI2, and IQUB signals were
weaker in Zmynd10−/− mice than in Zmynd10+/+ mice (Fig 5C–5E). A previous study in individ-
uals with a homozygous truncating ZMYND10mutation showed that DNAI2 was absent from
bronchial epithelial cells, whereas DNAH5 and DNALI1 remained in the cytoplasm [30]. There
were no differences in the mRNA levels of dynein arm components between Zmynd10+/+ and
Zmynd10−/− mice (Fig 3). These data suggested that ODA and IDA were unstable, likely due to
improper assembly in the absence of Zmynd10. We speculated whether the decrease in protein
levels of ZMYND10-interacting factors resulted from dysregulated transcription in Zmynd10−/−
mice. To investigate this possibility, we examined the transcript levels of these factors and of
DNAAFs, which are involved in dynein arm assembly [3], by RNA sequencing. There were no
differences in the mRNA levels of these proteins between Zmynd10+/+ and Zmynd10−/− mice
(Fig 5F–5H). These results suggested that ZMYND10 stabilizes dynein arm components and
their interaction partners at the protein level, but not at the transcript level.
ZMYND10 stabilized LRRC6 and dynein intermediate chain proteins
To determine whether ZMYND10 regulated its interaction partners and dynein arms at the
protein level, we investigated the effects of ZMYND10 on the stability of LRRC6, DNAI1, and
DNAI2 in a heterologous system. HEK 293T cells overexpressing LRRC6 and/or ZMYND10
were treated with cycloheximide (100 μg/mL) for up to 48 h to block protein synthesis (Fig
6A). Only 7.8% of LRRC6 remained after 48 h of treatment. However, this value was increased
to 44.4% when LRRC6 was co-expressed with ZMYND10 (Fig 6B), suggesting that ZMYND10
prevented LRRC6 degradation. Similarly, the amount of DNAI1 protein was increased from
30.9% to 64.1% by co-expressing ZMYND10 (Fig 6C and 6D), but not by co-expressing
ZMYND10-p.Gln366 mutant protein, which lacked the MYND domain and was identified in
a PCD patient [20] (S10 Fig), indicating that the MYND domain was necessary for the stabiliz-
ing effect. In contrast, the stability of DNAI2, which did not interact with ZMYND10 (S7K
and S7L Fig), was unaffected by ZMYND10 overexpression (S11 Fig). Given that both DNAI1
and DNAI2 levels were downregulated in Zmynd10−/− mice, we speculated that ZMYND10
stabilized DNAI1, which in turn stabilized DNAI2. To evaluate this possibility, we compared
the protein levels of DNAI2 upon co-expression with DNAI1 without or with ZMYND10.
DNAI2 was more stable in the presence of both DNAI1 and ZMYND10 than in the presence
of DNAI1 alone (Fig 6E and 6F, and S12 Fig). These results demonstrated that ZMYND10
Fig 4. ZMYND10 formed a cytoplasmic protein complex. (A) GST pulldown assays of the purified MYND domain of ZMYND10 or the full-length
protein. DNAI1, IQUB, REPTIN, LRRC6, and C21ORF59 in mTECs were pulled down by full-length ZMYND10, but not by the MYND domain
alone. (B) Interactors of ZMYND10. Dotted lines are interactions identified in this study, whereas solid lines are from previous studies. (C, D)
Immunofluorescence analysis of DNAI2 (green) or acetylated α-tubulin (Ac-α-tub, green) and C21ORF59 (red) in mTECs. At ALI day 14, C21ORF59
was observed in the cytoplasm whereas DNAI2 was localized in both cytoplasm and cilia in Zmynd10+/+ mTECs. DNAI2 and C21ORF59 were
downregulated in Zmynd10-deficient mTECs. Scale bars, 10 μm. (E) Immunofluorescence analysis of Ac-α-tub (green) and REPTIN (red) in mTECs.
REPTIN was localized in the cytoplasm of Zmynd10+/+ mTECs, but was absent in Zmynd10−/− cells. Scale bars, 10 μm.
https://doi.org/10.1371/journal.pgen.1007316.g004
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stabilized some of its interaction partners at the protein level and modulated the pre-assembly
of intermediate chains by stabilizing DNAI1.
Discussion
In this study, we generated and characterized Zmynd10−/− mice as a model for human PCD.
The mice exhibited loss of ciliary motility and ODA and IDA components without disruption
of ciliogenesis, thereby recapitulating the phenotypes associated with ZMYND10mutations in
humans and serving as an appropriate model to study PCD pathogenesis.
The assembly of dynein arms into motile cilia is a complex process involving many regula-
tory factors, including DNAAFs and chaperones, that contribute to the stabilization, folding,
and pre-assembly of dynein arm components [15, 24, 31] into multiprotein complexes that
undergo intraflagellar transport into the axoneme for attachment to peripheral microtubules
[31]. In Chlamydomonas, dynein arms exist as intermediate-chain/heavy-chain (IC-HC), light
chain, and docking complexes [12]. During ODA pre-assembly, HCs, such as DNAH5 or
DNAH11, are attached to ICs, DNAI1 (IC1), and DNAI2 (IC2). This process is facilitated by
DNAAF1, DNAAF2, and DNAAF4, while DNAAF3 is proposed to act during the final stages
of chaperone dissociation [15]. IC-HC assembly fails in the absence of the IC subunit [12]. Bio-
chemical analyses of Zmynd10−/− mice showed that DNAI1 and DNAI2 are downregulated,
suggesting that ZMYND10 stabilizes these two proteins or mediates their assembly. Given that
formation of the IC complex precedes IC-HC assembly, the reduced levels of DNAI1 and
DNAI2 may account for the observed decrease in an ODA HC, DNAH5.
In this study, we demonstrated that ZMYND10 formed a cytoplasmic protein network
comprised of LRRC6, C21ORF59, DYX1C1, IQUB, REPTIN, and HSC70. The interaction
between LRRC6 and REPTIN is essential for cilia motility in zebrafish, although this function
is independent of its known role as a transcriptional regulator [28]. Similarly, although
ZMYND10 binds to REPTIN, the expression levels of various dynein arm components and
interactors of ZMYND10 were not diminished in Zmynd10−/− mice, ruling out transcriptional
regulation of these factors as a mechanism underlying ODA and IDA defects. We previously
showed that DNAH5 and DNALI1 mRNAs were downregulated in human tracheal epithelial
cells in which an shRNA targeting ZMYND10 was delivered by lentivirus. This discrepancy
between in vivo mouse and cell line data may be due to artefacts resulting from lentiviral vec-
tor integration [32]. C21ORF59 interacts with LRRC6, DNAAF1, and Dvl to regulate polariza-
tion as well as ciliary motility [29]. DYX1C1 interacts with KTU, HSP70, HSP90, and T-
complex chaperonin [14, 16], whereas REPTIN interacts with PIH1D1 [33], which contains a
PIH (protein interacting with HSP90) domain implicated in the pre-assembly of dynein arms
[34]. PIH1D3 interacts with KTU, DYX1C1, and HSP90 [23, 24] and is implicated in the for-
mation of the IC complex, as evidenced by its interaction with DNAI2 and the downregulation
of DNAI1 and DNAI2 in Pih1d3−/− mouse sperm [24, 35]. ZMYND10 is functionally similar
to PIH1D3 in that both proteins interact with DYX1C1 and heat shock proteins; moreover,
Fig 5. Dynein arm subunits and interaction partners of ZMYND10 were downregulated in Zmynd10−/− mice. (A) Representative immunoblot analyses
of DNAH7, DNAI2, DNAI1, IQUB, LRRC6, C21ORF59, and ZMYND10 in the testis extracts from Zmynd10+/+ and Zmynd10−/− mice. (B) Bar graphs
represent band intensities of the blot shown in panel A, and data represent the mean ± SD of more than three independent experiments. Band intensities
were normalized to β-actin. P< 0.05; P< 0.005; t-test. (C–E) Immunofluorescence analysis of tracheal multiciliated epithelia in Zmynd10+/+ and
Zmynd10−/− mice. (C) DNAH5 (red), an ODA heavy chain protein, localized to both cilia and cytoplasm of the Zmynd10+/+ trachea, but was almost
completely absent from the Zmynd10−/− trachea. DNAI2 (red) was present in both the cilia and cytoplasm in the Zmynd10+/+ trachea and colocalized with
acetylated α-tubulin (Ac-α-tub) along cilia. However, DNAI2 expression was negligible in the Zmynd10−/− trachea (D). IQUB (red), a cytoplasmic protein
and ZMYND10 interaction partner, was almost undetectable in the Zmynd10−/− trachea (E). Scale bars, 10 μm. (F–H) Graphs comparing reads per
kilobase of transcript per million mapped reads (RPKM) of dynein arm assembly factors and ZMYND10-interacting proteins in the testis (F), lung (G),
and brain (H) tissues of Zmynd10+/+ and Zmynd10−/− mice.
https://doi.org/10.1371/journal.pgen.1007316.g005
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ICs are reduced in mice lacking Zmynd10 or Pih1d3 [35]. ZMYND10 interacts with HSC70, a
member of the HSP70 family. HSC70 is involved in diverse cellular processes, including pro-
tein folding and protein degradation, and exerts its chaperone activity by cooperation with
cochaperones and by binding to nascent or unfolded polypeptides through the substrate bind-
ing domain in an ATP-dependent manner [36]. Therefore, it is possible that ZYMND10 affects
the stability of DNAI1 through cooperation with HSC70.
Currently, there is no curative therapy for PCD. For PCD resulting from a defective dynein
arm component, the component should be replaced with a normal one. However, this will be
challenging considering the huge size of some dynein components. For example, the coding
region of DNAH5, which is most frequently mutated in PCD [17], is about 15.6 kb, encoding a
protein of 529 kDa. In this regard, PCD resulting from defects in DNAAFs or other cyto-
plasmic proteins is different in that dynein arm components are not compromised, but their
cytoplasmic assembly or trafficking is defective. In this study, we demonstrated that the pro-
tein levels of DNAI1 and DNAI2 were reduced in Zmynd10−/− mice due to the decreased sta-
bility of DNAI1 in the absence of ZYMND10. Therefore, increasing protein stability of DNAI1
can be considered as a potential treatment.
In conclusion, our results demonstrated that several cytoplasmic proteins, including
ZMYND10, formed a protein network in motile ciliated cells that, in conjunction with chaper-
one proteins, modulated various aspects of dynein arm pre-assembly. ZMYND10 specifically
functioned in the early steps of this process by regulating DNAI1 stability or folding, thereby
controlling IC assembly (S13 Fig). These findings provide insights into the molecular mecha-
nisms involved in dynein arm assembly and the pathogenic basis for PCD-associated defects.
This will also help to develop pharmacological interventions for PCD caused by defects in the
cytoplasmic nonaxonemal components of motile cilia.
Materials and methods
Ethics statement
The animal protocol was reviewed and approved by the Institutional Animal Care and Use
Committee of University of Michigan (#08619), Boston Children’s Hospital (#13-01-2283),
and Yonsei University College of Medicine (#2015–0178). All animals were handled in accor-
dance with the Guidelines for the Care and Use of Laboratory Animals.
Mice
Targeted Zmynd10tm1(KOMP)Wtsi embryonic stem cells were obtained from the Knockout
Mouse Project Repository and injected into blastocysts. Chimeric mice were bred with C57BL/
6J mice to establish germline transmission. Wild-type littermates were used as controls for
Zmynd10−/− mice. Genotyping was performed by standard PCR using the primers Zmyn-
d10-ex2F (50-TGGAGGAGCTTGGAACTGAC-30), Zmynd10-ex2R (50-GGAGGCAGACA-
CAGTTAGGC-30), and CSD-RAF5-F (50-ACACCTCCCCCTGAACCTGAAA-30, SR1 (50-TG
CTTTATTGTGCGAAAGGAAGAGGG-30).
Fig 6. ZMYND10 stabilized LRRC6 and intermediate chain proteins of ODA. The stability of LRRC6, DNAI1, and DNAI2 proteins was examined using
protein stability assays. Protein samples were harvested at the indicated times after treatment with cycloheximide (100 μg/mL).(A, B) Representative
immunoblots of LRRC6 stability assays (A). The stability of LRRC6 was increased upon co-expression of ZMYND10 (B). (C, D) Representative
immunoblots of DNAI1 stability assays (C). DNAI1 stability was increased by co-expression of ZMYND10 (D). (E, F) Representative immunoblots of
DNAI2 stability assays (E). DNAI2 was stabilized by co-expression of both DNAI1 and ZMYND10 (F). Data are representative of at least three independent
experiments, and band intensities were normalized to β-actin. P< 0.05; P< 0.005; t-test.
https://doi.org/10.1371/journal.pgen.1007316.g006
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β-Galatosidase staining
P1 or P28 mice were sacrificed, and the testes and lungs were dissected. After three washes
with phosphate-buffered saline (PBS), the tissues were fixed in 4% paraformaldehyde
(PFA)/0.02% Nonidet (N)P-40 for 2 h at room temperature and permeabilized with 0.02%
NP-40 in PBS for 1 h. Samples were incubated overnight at 37˚C in X-gal staining solution
composed of 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.01% sodium deoxycho-
late, 0.02% NP-40, and 1 mg/mL X-gal in PBS. They were then washed three times with PBS
for 5 min each and post-fixed with 4% PFA for 24 h before embedding within paraffin. Sec-
tions (10 μm thick) were deparaffinized and rehydrated through a graded series of ethanol
concentrations followed by counterstaining with Nuclear Fast Red (Vector Laboratories,
Burlingame, CA, USA).
Histology
The lung and snout tissue specimens were fixed using 10% formalin for 24 h. The tissues were
sectioned (5 μm thickness) and stained with hematoxylin and eosin, or periodic acid-Schiff for
histological examination.
TEM analysis
The tracheas of Zmynd10+/+ and Zmynd10−/− mice at P14 were dissected and fixed using 2.5%
glutaraldehyde, 1.25% PFA, and 0.03% picric acid in 0.1 M sodium cacodylate buffer (pH 7.4)
overnight at 4˚C. Samples were then processed for TEM analysis using standard techniques.
Videomicroscopy of the ependymal cilia in mice
P16 mice were deeply anesthetized and then decapitated. The brain was rapidly removed and
immersed in ice-cold Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO,
USA). Sagittal sections of 150-μm thickness were cut using a vibratome (VT1200S; Leica, Wet-
zlar, Germany). Sections from the third ventricle were visualized on an Axio Observer A1
microscope using a 63× phase contrast objective lens (LD Plan-Neofluor 0.75 Corr Ph2 M27;
Carl Zeiss, Jena, Germany) equipped with a high-speed charge-coupled device camera (opti-
MOS sCMOS; QImaging, Surrey, BC, Canada). Movies were acquired at 100 frames/s.
Antibodies
A polyclonal antibody recognizing the C-terminal sequence (amino acids 339–362, DRLER-
ENKGKWQAIAKHQLQHVFS) of mouse ZMYND10 was recovered from rabbits injected
with the corresponding antigen (AbFrontier, Seoul, Korea). LRRC6 and DNAH5 antibodies
were previously described [37, 38]. Antibodies against DNAI2 (H00064446-M01; Abnova, Tai-
pei, Taiwan); REPTIN (ab89942; Abcam, Cambridge, UK); DNAH7 (NBP1-93613) and
DNAI1 (SAB4501181; both from Novus Biologicals, Littleton, CO, USA); IQUB (HPA020621)
and TCTEX1D1 (HPA028420; both from Sigma-Aldrich); acetylated α-tubulin (T7451 from
Sigma-Aldrich and 5335S from Cell Signaling Technology, Danvers, MA, USA); FLAG
(#8146) and Myc (#2276; both from Cell Signaling Technology); and C21ORF59 (sc-365792)
and β-actin (sc-1615; both from Santa Cruz Biotechnology) were purchased from commercial
sources. Secondary antibodies were purchased from Invitrogen and Santa Cruz Biotechnology
for immunofluorescence and immunoblotting analyses, respectively.
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Immunofluorescence analysis
mTECs grown on inserts were fixed using 4% PFA for 10 min and permeabilized with 0.1%
Triton X-100 for 20 min at room temperature. The tracheal tissue was fixed in 4% paraformal-
dehyde overnight at 4˚C, embedded in a paraffin blocks, and cut into 5-μm-thick sections. The
sections were then mounted on slides, deparaffinized, and rehydrated through a graded series
of ethanol concentrations. After rehydration, antigen retrieval was performed by boiling sec-
tions for 30 min using a Retrieve-All Antigen unmasking system 1 (pH 8; BioLegend, San
Diego, CA, USA). Sections were permeabilized with 1% sodium dodecyl sulfate for 10 min at
room temperature. mTECs and trachea samples incubated in blocking buffer containing 10%
donkey serum and 1% bovine serum albumin for 1 h at room temperature. Samples were incu-
bated overnight at 4˚C with primary antibodies diluted in blocking buffer. After washes with
PBS, samples were incubated with secondary antibodies and 40,6-diamidino-2-phenylindole
for 30 min at room temperature, washed, and covered with mounting medium and cover slips.
Images were acquired using an SP5X laser scanning microscope (Leica) or LSM 700 micro-
scope (Carl Zeiss).
mTEC cultures
mTECs were isolated from Zmynd10+/+ and Zmynd10−/− mice at P14 as previously described
[39]. Briefly, cells were isolated by overnight digestion with pronase (Roche Diagnostics, India-
napolis, IN, USA) at 4˚C and then separated from contaminating fibroblasts by incubation in
mTEC basal medium on a Primaria cell culture plate (Corning Inc., Corning, NY, USA) for
3–4 h. mTECs were seeded in collagen-coated apical chambers of transwell permeable sup-
ports (0.4-μm polyester membrane; Corning Inc.). Proliferation medium was applied to the
apical and basal chambers of the wells, and cells were cultured at 37˚C in 5% CO2 [40]. For
ALI culture conditions, the medium was removed from the apical chamber when mTECs
became confluent, and differentiation medium was added to the basal chamber.
RNA sequencing
Total RNA was isolated from the brain (P14), lung (P14), and testis (P21) tissues obtained
from Zmynd10+/+ and Zmynd10−/− mice using a Qiagen RNA extraction kit (Qiagen, Valencia,
CA, USA). RNA sequencing was performed by Theragen Etex (Suwon, Korea). Libraries were
constructed with a TruSeq RNA Library Sample Prep kit (Illumina, San Diego, CA, USA), and
the enriched library was sequenced on an Illumina HiSeq 2500 system. Sequence reads were
mapped against the mouse reference genome (NCBI GRCm38/mm10) and analyzed using
CLC Genomics Workbench v.9.0.1 software (CLC Bio, Cambridge, MA, USA).
Cell culture and transfection
HEK 293T cells were maintained in DMEM supplemented with 10% FBS and penicillin (50
IU/mL)/streptomycin (50 μg/mL). The cells were transfected with plasmids using Lipofecta-
mine PLUS reagent (Invitrogen).
Immunoblotting, immunoprecipitation, and GST pulldown assays
Experiments were performed as previously described [41]. Immunoblotting was quantified by
densitometry using ImageJ software (National Institutes of Health, Bethesda, MD, USA).
Immunoprecipitation was performed using EZview Red anti-FLAG M2 or anti-c-Myc affinity
gels (Sigma-Aldrich). Pulldown assays with GST-ZMYND10 and GST-MYND were per-
formed as previously described [20].
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Protein stability assay
Cycloheximide chase was used to assess the stability of LRRC6, DNAI1, and DNAI2.
HEK293T cells were transfected with Myc-tagged LRRC6, DNAI1, or DNAI2 with or without
FLAG-tagged ZMYND10; at 24 h post-transfection, cells were treated with 100 μg/mL cyclo-
heximide (C4859; Sigma-Aldrich) to inhibit new protein synthesis. Cells were harvested at pre-
determined time points, and LRRC6, DNAI1, and DNAI2 levels were detected by western
blotting.
Statistical analysis
Results are presented as means ± standard errors or standard deviations for the indicated
number of experiments. Statistical analysis of continuous data was performed with two-tailed
Student’s t-test or one-way analysis of variance, with Dunnet’s, Bonferroni, or Dunn post hoc
test, as appropriate. Results with P values of less than 0.05 were considered statistically
significant.
Supporting information
S1 Fig. Generation and validation of Zmynd10-targeted alleles. (A) Diagram of Zmynd10-
targeted alleles.
(B) Wild-type, heterozygous, and homozygous sex-matched littermates were genotyped by
PCR based on the presence of the neomycin cassette, exon 2, exon 3, or exon 4. The wild-type
allele was 529 bp, and the mutant allele was 764 bp.
(C–F) X-gal staining of lungs (C and D) and testes (E and F) of Zmynd10 wild-type and heterozy-
gote mice. Each section was counterstained with nuclear fast red. X-gal staining in Zmynd10+/-
lung sections confirms Zmynd10 expression in the bronchiole. Scale bars, 200 μm. (E and F) X-
gal staining revealed that Zmynd10 was distributed in spermatocytes to spermatids in Zmynd10+/-
testis. Scale bars, 100 μm.
(TIF)
S2 Fig. Anti-ZMYND10 antibody generation and validation. (A) Western blot analysis of
HEK 293T cells transfected with FLAG-ZMYND10 and mouse testis lysates. For each well,
50 μg protein from the testis of Zmynd10+/+ and Zmynd10-/- mice was used for western blot
analysis. ZMYND10 was located at approximately 50 kDa.
(B and C) Immunofluorescence analysis of the tracheal epithelium in Zmynd10+/+ (B) and
Zmynd10-/- (C) mice. ZMYND10 (red) was localized in the apical membrane and not in cilia
labeled with acetylated α-tubulin (Ac-α-tub, green) in the tracheas of Zmynd10+/+ mice (B).
However, ZMYND10 was completely absent from Zmynd10-/- mice (C). Scale bars, 10 μm.
(D and E) Immunofluorescence of acetylated-α-tubulin, γ-tubulin (γ-tub, red), and
ZYMND10 in the tracheal epithelium of Zmynd10+/+ mice. ZMYND10 did not colocalize with
γ-tubulin.
(TIF)
S3 Fig. Zmynd10-/- mice were runts and developed hydrocephalus and/or situs inversus. (A
and B) Mouse growth. (A) Photographs of Zmynd10 wild-type and homozygous mice.
Zmynd10-/- mice were notably smaller than Zmynd10+/+ siblings. (B) Body weights were quan-
tified at 10 days of age.
(C) Survival graph of the indicated genotypes and numbers (n).
(D) Lungs extracted from a P29-old Zmynd10-/- mouse. Lobular structures were completed
deteriorated and alveolar spaces were collapsed.
(E and F) Consistent with randomization of left-right body asymmetry, Zmynd10-/- mice
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showed situs inversus (F). The locations of stomach, heart, liver and spleen are indicated. H,
heart; K, kidney; Lu, lung; Sp, spleen; St, stomach.
(TIF)
S4 Fig. Inflammation observed in the tracheas of Zmynd10-/- mice. TEM images of tracheal
epithelia. Both mice generated cilia normally. In contrast to Zmynd10+/+ mice (A), Zmynd10-/-
mice (B) exhibited cellular debris in some parts of the tracheal epithelia. Black and white
arrowheads are basal bodies and ciliary axonemes, respectively. Black brackets indicate layers
of cellular debris and mucus. Scale bar, 500 μm.
(TIF)
S5 Fig. Individual channel images of immunofluorescence corresponding to Fig 2K and 2L.
mTEC cultures at ALI day 14 were stained with acetylated-α-tubulin (Ac-α-tub, green) and
DNAI2 (red). DNAI2 did not colocalize with acetylated α-tubulin and was significantly decreased
in Zmynd10−/− mTECs (B), suggesting that motile cilia lacked ODAs. Scale bar, 10 μm.
(TIF)
S6 Fig. Enrichment analysis of gene ontology (GO). GO terms of 77 significantly increased
(A) and 76 significantly reduced (B) genes in the testes of Zmynd10-/- mice compared with
those in Zmynd10+/+ mice. Gene ontology categories representing molecular function (MF),
cellular component (CC), and biological process (BP) were separately analyzed for enrich-
ment. Five of the most significantly enriched gene ontology terms in three categories were
plotted against–log (p value). t-test, p value< 0.05.
(TIF)
S7 Fig. ZMYND10 interacted with cytoplasmic proteins. (A–L) Interactions between FLAG-
tagged ZMYND10 and Myc-tagged IQUB (A and B), Myc-TCTEX1D1 (C and D),
DYX1C1-V5 (E and F), Myc-C21ORF59 (G and H), Myc-DNAI1 (I and J), or Myc-DNAI2 (K
and L). All constructs were cotransfected into HEK 293T cells and co-immunoprecipitated
with anti-FLAG antibodies (A, C, E, G, I, and K) or anti-Myc antibodies (B, D, F, H, J, and L).
The immunoblots indicated that antibodies did not show nonspecific bands. Immunoprecipi-
tation showed protein-protein interactions between ZMYND10 and IQUB, TCTEX1D1,
DYX1C1, C21ORF59, and DNAI1 (A–J). However, ZMYND10 did not interact with DNAI2
(K and L).
(TIF)
S8 Fig. ZMYND10 interacted with HSC70. (A and B) Myc-HSC70 and FLAG-ZMYND10
were cotransfected into HEK 293T cells and co-immunoprecipitated with anti-FLAG antibod-
ies (A) or anti-Myc antibodies (B).
(C) FLAG-ZMYND10 was transfected into HEK 293T cells, co-immunoprecipitated with
anti-FLAG antibodies, and blotted with anti-HSC70 antibodies.
(TIF)
S9 Fig. Individual channel images of immunofluorescence corresponding to Fig 4C–4E.
mTEC cultures at ALI day 14 were stained for DNAI2 and C21ORF59 (A), acetylated α-tubu-
lin (Ac-α-tub) and C21ORF59 (B), and Ac-α-tub and REPTIN (C). REPTIN and C21ORF59,
both of which interact with ZMYND10, were significantly decreased in Zmynd10−/− mTECs.
Scale bar, 10 μm.
(TIF)
S10 Fig. The MYND domain of ZMYND10 was necessary for the stabilizing effect of the
protein. (A) Representative immunoblots of stability assays. Note that ZMYND10 stabilized
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DNAI1, whereas ZMYND10-p.Gln366, which lacked the MYND domain, failed to stabilize
DNAI1.
(B)Graph of band intensities. The graph is summarized from triplicate experiments, and the
band intensities were normalized to β-actin levels.
(C) Co-immunoprecipitation showing that ZMYND10-pGln366 did not interact with
DNAI1, indicating that the MYND domain was necessary for the interaction.
(TIF)
S11 Fig. DNAI2 was not stabilized by co-expression of ZMYND10. The stability of DNAI2
was examined by protein stability assays in HEK 293T cells. After treatment with cyclohexi-
mide (100 μg/mL), protein samples were harvested at the indicated times.
(A) Representative immunoblots. Note that protein levels of DNAI2 were not affected by
ZMYND10 co-expression.
(B) Graph of band intensities. The graph was summarized from triplicate experiments, and
the band intensities were normalized to β-actin levels.
(TIF)
S12 Fig. All experiments reflecting the graph corresponding to Fig 6E and 6F. The stability
of DNAI2 proteins was examined with protein stability assays. Protein samples were harvested
at the indicated times after treatment with cycloheximide (100 μg/mL). All four experiments
are summarized in Fig 6F.
(TIF)
S13 Fig. Function of ZMYND10 in the cytoplasmic pre-assembly of dynein arms. (A)
ZMYND10 binds to and stabilizes DNAI1. DNAI1 forms a complex with DNAI2, and heavy
chain proteins are then attached to the intermediate chain complex. ZMYND10 may also regu-
late proper folding of DNAI1 or the assembly of the intermediate chain complex.
(B)In the absence of ZMYND10, both DNAI1 and DNAI2 are unstable and degraded.
(TIF)
S14 Fig. Uncropped images of western blot data.
(TIF)
S1 Movie. Videomicroscopy of brain ventricles from a P16 wild-type mouse.
(MP4)
S2 Movie. Videomicroscopy of brain ventricles from a P16 Zmynd10-/- mouse.
(MP4)
S1 Table. Variation between initial and final frequencies of aedes aegypti NaV alleles from
São Paulo populations.
(XLSX)
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